Table 3.
Co-morbidities among admitted patients with PIVC phlebitis at University of Gondar hospital, Northwest Ethiopia, April 1, 2020 to August 31, 2020
| Variables | Frequency (No.) | Percentage (%) |
|---|---|---|
| Diabetes | ||
| Yes | 38 | 9.9 |
| No | 346 | 90.1 |
| Hypertension | ||
| Yes | 89 | 23.2 |
| No | 295 | 76.8 |
| HIV/AIDS | ||
| Yes | 24 | 6.3 |
| No | 159 | 41.4 |
| Unknown | 201 | 52.3 |
| Chronic kidney disease | ||
| Yes | 30 | 7.8 |
| No | 354 | 92.2 |
| Malignancy | ||
| Yes | 30 | 7.8 |
| No | 354 | 92.2 |
| Concomitant bacterial infections | ||
| Yes | 243 | 63.3 |
| No | 141 | 36.7 |
NB AIDS, acquired immune deficiency syndrome, HIV human immuno deficiency virus, PIVC peripheral intravenous catheter